[Anti-arrhythmia activity of the GABA derivative TZ-50-2].
Galenko-Iaroshevskiĭ
P A
PA
Uvarov
A V
AV
Linchenko
S N
SN
Popov
P B
PB
Popkov
B L
BL
Turovaia
A Iu
AIu
Tiukhteneva
Z I
ZI
Cherednik
I L
IL
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology* / Q000633:toxicity; D001145:Arrhythmias, Cardiac / Q000517:prevention & control*; D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000633:toxicity; D002415:Cats; D004285:Dogs; D004562:Electrocardiography; D004594:Electrophysiology; D005260:Female; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects / Q000503:physiopathology; D066298:In Vitro Techniques; D007928:Lethal Dose 50; D008297:Male; D011817:Rabbits; D051381:Rats; D026941:Sodium Channel Blockers; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000633:toxicity
D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D026941:Sodium Channel Blockers; C117739:hemisuccinate-4-oxy-3-benzylamino-N-benzylbutanamide; D005680:gamma-Aminobutyric Acid
Protivoaritmicheskaia aktivnost' proizvodnogo GAMK TZ-50-2.